Contract term.

No definition available.

Name:	nvax_ContractTerm
Namespace Prefix:	nvax_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Contract term additional years.

+ References

No definition available.

+ Details

Name:	nvax_ContractTermAdditionalYears
Namespace Prefix:	nvax_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Contract term after first sale.

+ References

No definition available.

+ Details

Name:	nvax_ContractTermAfterFirstSale
Namespace Prefix:	nvax_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Grant agreement

+ References

No definition available.

+ Details

Name:	nvax_GrantAgreement
Namespace Prefix:	nvax_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of initial funding development costs.

+ References

No definition available.

+ Details

Name:	nvax_InitialFundingDevelopmentCosts
Namespace Prefix:	nvax_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The percentage of the joint venture owned by others.

+ References

No definition available.

+ Details

Name:	nvax_JointVenturePercentageOwnedByOthers
Namespace Prefix:	nvax_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_OwnershipAxis=nvax_CPLBiologicalsPrivateLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=nvax_EquityMethodInvesteeOneMemberMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nvax_BillMelindaGatesFoundationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nvax_GlobalAccessCommitmentsAgreementGacaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nvax_HhsBardaContractAwardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nvax_CoalitionForEpidemicPreparednessInnovationsAwardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Grants, U.S. Government Contract and Joint Venture (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended								12 Months Ended			52 Months Ended
	Mar. 31, 2020	Sep. 30, 2015	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Contracts Revenue			$ 8,816	$ 2,507	$ 3,357	$ 3,982	$ 6,127	$ 7,735	$ 10,773	$ 9,653	$ 18,662	$ 34,288	$ 31,176
CPL Biologicals Private Limited [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			20.00%								20.00%			20.00%
Equity Method Investee One [Member] \| CPL Biologicals Private Limited [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Joint Venture Percentage Owned By Others			80.00%								80.00%			80.00%
Bill Melinda Gates Foundation [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Contracts Revenue											$ 8,400			$ 81,000
Grant Agreement											89,100
Bill Melinda Gates Foundation [Member] \| Maximum [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Grant Agreement		$ 89,100										$ 89,100
Global Access Commitments Agreement GACA [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Contract term after first sale		10 years										10 years
Contract term		15 years										15 years
Contract term additional years		5 years										5 years
Hhs Barda Contract Award [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Contracts Revenue											$ 7,500
Revenue			$ 7,500
Coalition for Epidemic Preparedness Innovations ("CEPI") [Member] \| Subsequent Event [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Initial Funding Development Costs	$ 4,000